On the public citation graph

Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer

https://doi.org/10.1016/j.ijrobp.2006.12.053

0 signed · 250 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1997.03550100097049openalex-snapshot

Cancer: Principles and Practice of Oncology

inferredcites →https://doi.org/10.1002/(sici)1097-0142(19960801)78:3<627::aid-cncr43>3.0.co;2-yopenalex-snapshot

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

inferredcites →https://doi.org/10.1002/(sici)1097-0142(19960801)78:3<627::aid-cncr43>3.3.co;2-eopenalex-snapshot

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970415)79:8<1516::aid-cncr11>3.0.co;2-0openalex-snapshot

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma

inferredcites →https://doi.org/10.1002/1097-0142(197312)32:6<1341::aid-cncr2820320609>3.0.co;2-aopenalex-snapshot

Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas

inferredcites →https://doi.org/10.1002/1097-0142(19811015)48:8<1705::aid-cncr2820480803>3.0.co;2-4openalex-snapshot

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

inferredcites →https://doi.org/10.1002/1097-0142(19921015)70:8<2061::aid-cncr2820700808>3.0.co;2-vopenalex-snapshot

Lymphatic flow in carcinoma of the head of the pancreas

inferredcites →https://doi.org/10.1002/jso.10159openalex-snapshot

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_25openalex-snapshot

Nonparametric Estimation from Incomplete Observations

inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_37openalex-snapshot

Regression Models and Life-Tables

inferredcites →https://doi.org/10.1007/pl00002424openalex-snapshot

Patterns of Failure Following CT-Based 3-D Irradiation for Malignant Glioma

inferredcites →https://doi.org/10.1016/0167-8140(92)90381-4openalex-snapshot

The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies

inferredcites →https://doi.org/10.1016/0360-3016(95)00060-copenalex-snapshot

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

inferredcites →https://doi.org/10.1016/0360-3016(95)02134-5openalex-snapshot

Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine

inferredcites →https://doi.org/10.1016/j.ijrobp.2005.06.029openalex-snapshot

Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1–3N0 non–small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation?

inferredcites →https://doi.org/10.1016/j.ijrobp.2006.07.537openalex-snapshot

2133

inferredcites →https://doi.org/10.1016/s0039-6060(95)80003-4openalex-snapshot

Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion

inferredcites →https://doi.org/10.1016/s0093-7754(01)80006-3openalex-snapshot

Combining Gemcitabine With Radiation in Pancreatic Cancer: Understanding Important Variables Influencing the Therapeutic Index

inferredcites →https://doi.org/10.1016/s0167-8140(03)00118-xopenalex-snapshot

Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma

inferredcites →https://doi.org/10.1016/s0360-3016(01)01708-4openalex-snapshot

Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma

inferredcites →https://doi.org/10.1016/s0360-3016(02)02980-2openalex-snapshot

Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer

inferredcites →https://doi.org/10.1016/s0360-3016(03)00435-8openalex-snapshot

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study

inferredcites →https://doi.org/10.1016/s0959-8049(02)00076-xopenalex-snapshot

Gemcitabine–radiotherapy in patients with locally advanced pancreatic cancer

inferredcites →https://doi.org/10.1038/sj.bjc.6600446openalex-snapshot

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

inferredcites →https://doi.org/10.1038/sj.bjc.6602001openalex-snapshot

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

inferredcites →https://doi.org/10.1053/clon.2002.0059openalex-snapshot

Locally Advanced Pancreatic Cancer Treated with Radiation and 5-Fluorouracil

inferredcites →https://doi.org/10.1080/01621459.1958.10501452openalex-snapshot

Nonparametric Estimation from Incomplete Observations

inferredcites →https://doi.org/10.1093/jnci/80.10.751openalex-snapshot

Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1

inferredcites →https://doi.org/10.1093/jnci/92.3.205openalex-snapshot

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

inferredcites →https://doi.org/10.1097/00000658-197902000-00012openalex-snapshot

A Multi-Institutional Comparative Trial of Radiation Therapy Alone and in Combination with 5-fluorouracil for Locally Unresectable Pancreatic Carcinoma

inferredcites →https://doi.org/10.1111/j.2517-6161.1972.tb00899.xopenalex-snapshot

Regression Models and Life-Tables

inferredcites →https://doi.org/10.1118/1.1785451openalex-snapshot

Incorporating model parameter uncertainty into inverse treatment planning

inferredcites →https://doi.org/10.1118/1.598063openalex-snapshot

Reporting and analyzing dose distributions: A concept of equivalent uniform dose

inferredcites →https://doi.org/10.1136/bmj.317.7172.1572openalex-snapshot

Survival probabilities (the Kaplan-Meier method)

inferredcites →https://doi.org/10.1159/000086993openalex-snapshot

Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer

inferredcites →https://doi.org/10.1177/030089160108700609openalex-snapshot

Concomitant Radiotherapy with Protracted 5-fluorouracil Infusion in Locally Advanced Carcinoma of the Pancreas: A Phase Ii Study

inferredcites →https://doi.org/10.1200/jco.1985.3.3.373openalex-snapshot

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

inferredcites →https://doi.org/10.1200/jco.1997.15.6.2403openalex-snapshot

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

inferredcites →https://doi.org/10.1200/jco.2001.19.22.4202openalex-snapshot

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer

inferredcites →https://doi.org/10.1200/jco.2002.11.149openalex-snapshot

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

inferredcites →https://doi.org/10.1200/jco.2004.10.112openalex-snapshot

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.4105openalex-snapshot

A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group Trial

inferredcites →https://doi.org/10.1245/aso.2006.03.039openalex-snapshot

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

inferredcites →https://doi.org/10.1385/ijgc:34:2-3:107openalex-snapshot

Cancer and Leukemia Group B (CALGB) 89805: Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas

inferredcites →https://doi.org/10.7326/0003-4819-114-9-819_4openalex-snapshot

Cancer: Principles and Practice of Oncology.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4706360openalex-extracted

Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study

inferred← citeshttps://doi.org/10.1002/acm2.13930openalex-snapshot

Evaluating motion of pancreatic tumors and anatomical surrogates using cine MRI in 0.35T MRgRT under free breathing conditions

inferred← citeshttps://doi.org/10.1002/cam4.70648openalex-snapshot

Multi‐Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor‐Tracking, Moderately Hypofractionated Intensity‐Modulated Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1002/cncr.25303openalex-snapshot

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma

inferred← citeshttps://doi.org/10.1002/cncr.25742openalex-snapshot

A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

inferred← citeshttps://doi.org/10.1002/jmrs.313openalex-snapshot

Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia

inferred← citeshttps://doi.org/10.1002/jso.21527openalex-snapshot

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5‐fluorouracil, and cisplatin followed by radiotherapy and 5‐fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

inferred← citeshttps://doi.org/10.1007/174_2010_2openalex-snapshot

The Locally Advanced Nonmetastatic Cancer

inferred← citeshttps://doi.org/10.1007/174_2013_870openalex-snapshot

Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-0-387-77498-5_44openalex-snapshot

Adjuvant Chemoradiation Therapy for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-0-387-92988-0_20openalex-snapshot

Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-1-4020-8900-8_22openalex-snapshot

Unresectable Locally Advanced Pancreatic Cancer: Concurrent Chemotherapy

inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_44-2openalex-snapshot

Adjuvant Chemoradiation Therapy for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_88-1openalex-snapshot

Role of Radiotherapy in Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_44openalex-snapshot

Adjuvant Chemoradiation Therapy for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_88openalex-snapshot

Role of Radiotherapy in Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-3-030-16924-4_20openalex-snapshot

Charged Particle Stereotactic Body Radiation Therapy

inferred← citeshttps://doi.org/10.1007/978-3-031-67743-4_19openalex-snapshot

Charged Particle Stereotactic Body Radiation Therapy

inferred← citeshttps://doi.org/10.1007/978-3-319-22780-1_7openalex-snapshot

Role of Radiation Therapy

inferred← citeshttps://doi.org/10.1007/978-3-319-42478-1_15openalex-snapshot

Pancreatic and Stomach Malignancies

inferred← citeshttps://doi.org/10.1007/978-3-319-62642-0_20openalex-snapshot

Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-3-319-98944-0_11openalex-snapshot

Role of Radiation for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-3-662-45934-8_7openalex-snapshot

Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-3-662-47181-4_38openalex-snapshot

Radiation Therapy

inferred← citeshttps://doi.org/10.1007/978-4-431-54883-6_9openalex-snapshot

Treatment Planning

inferred← citeshttps://doi.org/10.1007/978-4-431-55486-8_17openalex-snapshot

Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/978-981-99-3978-7_7openalex-snapshot

Treatment Planning

inferred← citeshttps://doi.org/10.1007/s00066-010-2094-5openalex-snapshot

Volumetric Modulated Arc Therapy for Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/s00066-013-0332-3openalex-snapshot

Comparison of four target volume definitions for pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s00066-013-0391-5openalex-snapshot

Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s00066-016-1053-1openalex-snapshot

Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s00280-007-0647-9openalex-snapshot

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

inferred← citeshttps://doi.org/10.1007/s00280-009-1193-4openalex-snapshot

A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s00280-012-1918-7openalex-snapshot

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s00535-013-0857-3openalex-snapshot

Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s10147-007-0763-xopenalex-snapshot

Chemoradiotherapy for unresectable pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s10238-025-01848-zopenalex-snapshot

Systematic review on the safety and efficacy of immune checkpoint inhibitors combined with stereotactic body radiotherapy in advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1007/s10620-014-3170-yopenalex-snapshot

Increased Rates of Duodenal Obstruction in Pancreatic Cancer Patients Receiving Modern Medical Management

inferred← citeshttps://doi.org/10.1007/s11605-010-1323-7openalex-snapshot

Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients

inferred← citeshttps://doi.org/10.1007/s11912-014-0388-yopenalex-snapshot

Management Options in Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1007/s12328-022-01750-1openalex-snapshot

Clinical course and treatment of radiation-induced hemorrhagic gastritis: a case series study

inferred← citeshttps://doi.org/10.1007/s13566-017-0313-8openalex-snapshot

Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma

inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00078-5openalex-snapshot

Carcinoma of the Pancreas

inferred← citeshttps://doi.org/10.1016/b978-0-323-87688-9.00019-2openalex-snapshot

Combining radiation and systemic therapy

inferred← citeshttps://doi.org/10.1016/b978-1-4160-5897-7.00039-1openalex-snapshot

Cancer of the Pancreas

inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00081-3openalex-snapshot

Carcinoma of the Pancreas

inferred← citeshttps://doi.org/10.1016/j.adro.2019.08.014openalex-snapshot

How Much Was the Elective Lymph Node Region Covered in Involved-Field Radiation Therapy for Locally Advanced Pancreatic Cancer? Evaluation of Overlap Between Gross Target Volume and Celiac Artery–Superior Mesenteric Artery Lymph Node Regions

inferred← citeshttps://doi.org/10.1016/j.adro.2021.100648openalex-snapshot

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer

inferred← citeshttps://doi.org/10.1016/j.adro.2024.101577openalex-snapshot

Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study

inferred← citeshttps://doi.org/10.1016/j.canrad.2010.10.001openalex-snapshot

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

inferred← citeshttps://doi.org/10.1016/j.clon.2009.09.024openalex-snapshot

Induction Chemotherapy Followed by Chemoradiation in Locally Advanced Pancreatic Cancer: an Effective and Well-tolerated Treatment

inferred← citeshttps://doi.org/10.1016/j.clon.2014.06.002openalex-snapshot

Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy

inferred← citeshttps://doi.org/10.1016/j.clon.2018.02.067openalex-snapshot

Stomach Dose–Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.clon.2020.06.019openalex-snapshot

Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma

inferred← citeshttps://doi.org/10.1016/j.ebiom.2018.12.060openalex-snapshot

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114236openalex-snapshot

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial

inferred← citeshttps://doi.org/10.1016/j.gie.2020.02.012openalex-snapshot

Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial

inferred← citeshttps://doi.org/10.1016/j.hoc.2015.04.005openalex-snapshot

Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.1016/j.hpb.2018.07.010openalex-snapshot

A simple matrix to predict treatment success and long-term survival among patients undergoing pancreatectomy

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.01.051openalex-snapshot

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.07.010openalex-snapshot

Evaluation of Four-Dimensional Computed Tomography-Based Intensity-Modulated and Respiratory-Gated Radiotherapy Techniques for Pancreatic Carcinoma

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.01.042openalex-snapshot

Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.02.003openalex-snapshot

Characterization of Pancreatic Tumor Motion Using Cine MRI: Surrogates for Tumor Position Should Be Used With Caution

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.05.071openalex-snapshot

Radiation Dose–Volume Effects in the Stomach and Small Bowel

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.06.009openalex-snapshot

Use of Respiratory-Correlated Four-Dimensional Computed Tomography to Determine Acceptable Treatment Margins for Locally Advanced Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.09.075openalex-snapshot

A Dosimetric Model of Duodenal Toxicity After Stereotactic Body Radiotherapy for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.04.058openalex-snapshot

Pancreatic Cancer Tumor Size on CT Scan Versus Pathologic Specimen: Implications for Radiation Treatment Planning

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.05.006openalex-snapshot

Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.05.046openalex-snapshot

Positional Reproducibility of Pancreatic Tumors Under End-Exhalation Breath-Hold Conditions Using a Visual Feedback Technique

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.08.050openalex-snapshot

Phase I Study of Conformal Radiotherapy and Concurrent Full-Dose Gemcitabine With Erlotinib for Unresected Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.10.020openalex-snapshot

Interfractional Reproducibility in Pancreatic Position Based on Four-Dimensional Computed Tomography

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.01.050openalex-snapshot

Interfractional Dose Variations in Intensity-Modulated Radiotherapy With Breath-Hold for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.07.013openalex-snapshot

Concurrent Radiotherapy and Gemcitabine for Unresectable Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Survival

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.08.008openalex-snapshot

Treatment of Locally Advanced Pancreatic Cancer: The Role of Radiation Therapy

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.08.022openalex-snapshot

Radiation Therapy With Full-Dose Gemcitabine and Oxaliplatin for Unresectable Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.09.022openalex-snapshot

Dose–Volume Analysis of Predictors for Gastrointestinal Toxicity After Concurrent Full-Dose Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.10.050openalex-snapshot

High-dose Helical Tomotherapy With Concurrent Full-dose Chemotherapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.11.050openalex-snapshot

Radiotherapy Technical Considerations in the Management of Locally Advanced Pancreatic Cancer: American-French Consensus Recommendations

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.12.026openalex-snapshot

Analysis of Dosimetric Parameters Associated With Acute Gastrointestinal Toxicity and Upper Gastrointestinal Bleeding in Locally Advanced Pancreatic Cancer Patients Treated With Gemcitabine-Based Concurrent Chemoradiotherapy

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2012.02.051openalex-snapshot

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.09.044openalex-snapshot

In Regard to Kelly et al

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.06.066openalex-snapshot

Single- versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.10.058openalex-snapshot

Modeling Pancreatic Tumor Motion Using 4-Dimensional Computed Tomography and Surrogate Markers

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2015.12.362openalex-snapshot

Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2018.12.052openalex-snapshot

Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2020.11.017openalex-snapshot

Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2021.02.008openalex-snapshot

Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/j.meddos.2009.11.001openalex-snapshot

Conkiss: Conformal Kidneys Sparing 3D Noncoplanar Radiotherapy Treatment for Pancreatic Cancer As an Alternative to IMRT

inferred← citeshttps://doi.org/10.1016/j.meddos.2014.10.006openalex-snapshot

Ipsilateral kidney sparing in treatment of pancreatic malignancies using volumetric-modulated arc therapy avoidance sectors

inferred← citeshttps://doi.org/10.1016/j.pan.2014.07.002openalex-snapshot

Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature

inferred← citeshttps://doi.org/10.1016/j.phyplu.2021.100133openalex-snapshot

Phytochemical based sestrin2 pharmacological modulators in the treatment of adenocarcinomas

inferred← citeshttps://doi.org/10.1016/j.prro.2011.06.009openalex-snapshot

Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation

inferred← citeshttps://doi.org/10.1016/j.prro.2013.01.005openalex-snapshot

Radiation dose responses for chemoradiation therapy of pancreatic cancer: An analysis of compiled clinical data using biophysical models

inferred← citeshttps://doi.org/10.1016/j.prro.2015.10.006openalex-snapshot

Four-dimensional computed tomography prediction of inter- and intrafractional upper gastrointestinal tumor motion during fractionated stereotactic body radiation therapy

inferred← citeshttps://doi.org/10.1016/j.radonc.2010.08.007openalex-snapshot

Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: Evaluation and reproducibility

inferred← citeshttps://doi.org/10.1016/j.radonc.2010.10.016openalex-snapshot

Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2011.05.038openalex-snapshot

Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2011.12.029openalex-snapshot

A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis

inferred← citeshttps://doi.org/10.1016/j.radonc.2012.07.004openalex-snapshot

Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: Implications for radiation therapy planning

inferred← citeshttps://doi.org/10.1016/j.radonc.2013.04.010openalex-snapshot

A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy

inferred← citeshttps://doi.org/10.1016/j.radonc.2013.05.011openalex-snapshot

Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma

inferred← citeshttps://doi.org/10.1016/j.radonc.2016.03.021openalex-snapshot

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2016.07.012openalex-snapshot

Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2017.04.010openalex-snapshot

Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy

inferred← citeshttps://doi.org/10.1016/j.radonc.2017.04.024openalex-snapshot

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

inferred← citeshttps://doi.org/10.1016/j.radonc.2018.05.007openalex-snapshot

Respiratory motion of lymph node stations in pancreatic cancer: Analyses using contrast-enhanced four-dimensional computed tomography

inferred← citeshttps://doi.org/10.1016/j.radonc.2019.03.012openalex-snapshot

Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2021.03.038openalex-snapshot

Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer

inferred← citeshttps://doi.org/10.1016/j.semradonc.2018.02.007openalex-snapshot

How Histopathologic Tumor Extent and Patterns of Recurrence Data Inform the Development of Radiation Therapy Treatment Volumes in Solid Malignancies

inferred← citeshttps://doi.org/10.1016/j.tranon.2014.07.005openalex-snapshot

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

inferred← citeshttps://doi.org/10.1016/s1278-3218(10)70012-3openalex-snapshot

Cancer du pancréas

inferred← citeshttps://doi.org/10.1016/s1470-2045(13)70021-4openalex-snapshot

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

inferred← citeshttps://doi.org/10.1038/nrclinonc.2011.182openalex-snapshot

The importance of local control in pancreatic cancer

inferred← citeshttps://doi.org/10.1038/nrclinonc.2013.66openalex-snapshot

Advanced-stage pancreatic cancer: therapy options

inferred← citeshttps://doi.org/10.1038/nrgastro.2010.98openalex-snapshot

The role of radiotherapy in locally advanced pancreatic carcinoma

inferred← citeshttps://doi.org/10.1038/onc.2012.598openalex-snapshot

Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1

inferred← citeshttps://doi.org/10.1038/sj.bjc.6604287openalex-snapshot

Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells

inferred← citeshttps://doi.org/10.1055/s-0033-1356220openalex-snapshot

S3-Leitlinie zum exokrinen Pankreaskarzinom

inferred← citeshttps://doi.org/10.1093/annonc/mdn281openalex-snapshot

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

inferred← citeshttps://doi.org/10.1097/coc.0000000000000003openalex-snapshot

Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.1097/coc.0000000000000200openalex-snapshot

Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer

inferred← citeshttps://doi.org/10.1097/coc.0b013e3182467f22openalex-snapshot

A Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma

inferred← citeshttps://doi.org/10.1097/mpa.0b013e318291fbc5openalex-snapshot

Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.

inferred← citeshttps://doi.org/10.1117/1.jmi.1.2.025001openalex-snapshot

In vivo reproducibility of robotic probe placement for a novel ultrasound-guided radiation therapy system

inferred← citeshttps://doi.org/10.1118/1.4735323openalex-snapshot

SU‐E‐T‐256: Radiation Dose Responses for Chemoradiation Therapy of Pancreatic Cancer: An Analysis of Compiled Clinical Data Using Biophysical Models

inferred← citeshttps://doi.org/10.1118/1.4887797openalex-snapshot

A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas

inferred← citeshttps://doi.org/10.1118/1.4964790openalex-snapshot

Unwrapping 3D complex hollow organs for spatial dose surface analysis

inferred← citeshttps://doi.org/10.1120/jacmp.v14i5.4252openalex-snapshot

Effects of interportal error on dose distribution in patients undergoing breath‐holding intensity‐modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method

inferred← citeshttps://doi.org/10.1120/jacmp.v16i2.4896openalex-snapshot

Baseline correction of a correlation model for improving the prediction accuracy of infrared marker‐based dynamic tumor tracking

inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-07-4072openalex-snapshot

The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer

inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-08-2080openalex-snapshot

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-16-0870openalex-snapshot

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma

inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-19-4155openalex-snapshot

Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research

inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-20-4003openalex-snapshot

Drug–Radiotherapy Combination Trial Developments—Letter

inferred← citeshttps://doi.org/10.1159/000375402openalex-snapshot

Full-Dose Gemcitabine Is a More Effective Chemotherapeutic Agent Than 5-Fluorouracil for Concurrent Chemoradiotherapy as First-Line Treatment in Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1186/1471-230x-11-123openalex-snapshot

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

inferred← citeshttps://doi.org/10.1186/1471-2407-13-419openalex-snapshot

Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial

inferred← citeshttps://doi.org/10.1186/1748-717x-5-60openalex-snapshot

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer

inferred← citeshttps://doi.org/10.1186/1748-717x-5-64openalex-snapshot

The role of radiotherapy in multimodal treatment of pancreatic carcinoma

inferred← citeshttps://doi.org/10.1186/1748-717x-6-147openalex-snapshot

Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies

inferred← citeshttps://doi.org/10.1186/1748-717x-7-203openalex-snapshot

The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer

inferred← citeshttps://doi.org/10.1186/1748-717x-8-148openalex-snapshot

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience

inferred← citeshttps://doi.org/10.1186/1748-717x-8-44openalex-snapshot

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

inferred← citeshttps://doi.org/10.1186/1748-717x-9-192openalex-snapshot

The analysis of respiration-induced pancreatic tumor motion based on reference measurement

inferred← citeshttps://doi.org/10.1186/s12885-019-5307-zopenalex-snapshot

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)

inferred← citeshttps://doi.org/10.1186/s12885-023-11228-zopenalex-snapshot

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

inferred← citeshttps://doi.org/10.1186/s13014-016-0729-0openalex-snapshot

MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells

inferred← citeshttps://doi.org/10.1186/s13014-018-1063-5openalex-snapshot

Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.1186/s13014-018-1138-3openalex-snapshot

Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

inferred← citeshttps://doi.org/10.1186/s13014-019-1345-6openalex-snapshot

Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

inferred← citeshttps://doi.org/10.1186/s13014-020-01592-6openalex-snapshot

Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head

inferred← citeshttps://doi.org/10.1186/s13014-020-01731-zopenalex-snapshot

Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results

inferred← citeshttps://doi.org/10.1186/s13014-024-02477-8openalex-snapshot

A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study

inferred← citeshttps://doi.org/10.1200/jco.19.00730openalex-snapshot

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1200/jco.2007.13.0054openalex-snapshot

Radiotherapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1200/jco.2007.13.9014openalex-snapshot

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

inferred← citeshttps://doi.org/10.1200/jco.2008.19.7921openalex-snapshot

Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review

inferred← citeshttps://doi.org/10.1200/jco.2010.30.3446openalex-snapshot

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

inferred← citeshttps://doi.org/10.1200/jco.2011.34.8904openalex-snapshot

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

inferred← citeshttps://doi.org/10.1245/s10434-014-4225-1openalex-snapshot

Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

inferred← citeshttps://doi.org/10.1259/bjr.20160815openalex-snapshot

Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker

inferred← citeshttps://doi.org/10.1371/journal.pone.0166606openalex-snapshot

Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients

inferred← citeshttps://doi.org/10.15406/jnhfe.2017.07.00242openalex-snapshot

Can Nigella Sativa and Pure Honey Improved Chemoradiotherapy Effects in Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.1593/tlo.07106openalex-snapshot

Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells

inferred← citeshttps://doi.org/10.1593/tlo.07118openalex-snapshot

Radiosensitization By Gemcitabine Fixed-Dose-Rate Infusion Versus Bolus Injection in a Pancreatic Cancer Model

inferred← citeshttps://doi.org/10.1593/tlo.07121openalex-snapshot

Gemcitabine-Mediated Radiosensitization of Human Soft Tissue Sarcoma

inferred← citeshttps://doi.org/10.1593/tlo.13724openalex-snapshot

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study

inferred← citeshttps://doi.org/10.1634/theoncologist.2009-s105openalex-snapshot

Recent Advances in Combined Modality Therapy

inferred← citeshttps://doi.org/10.18632/oncotarget.2500openalex-snapshot

Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation

inferred← citeshttps://doi.org/10.18632/oncotarget.3562openalex-snapshot

Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy

inferred← citeshttps://doi.org/10.21037/jgo-21-361openalex-snapshot

Pathobiology, irradiation dosimetric parameters and therapy of radiation-induced gastric damage: a narrative review

inferred← citeshttps://doi.org/10.21037/jgo-21-503openalex-snapshot

Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy

inferred← citeshttps://doi.org/10.21037/jgo.2017.08.04openalex-snapshot

Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer—patterns of care and overall survival

inferred← citeshttps://doi.org/10.21203/rs.3.rs-3696567/v1openalex-snapshot

Effect of First-line Chemotherapy Alone Versus First-line Chemotherapy Plus Radiotherapy on Survival in Patients with Locally Advanced Pancreatic Cancer in the IMRT era: A Retrospective Cohort Study

inferred← citeshttps://doi.org/10.2147/ott.s91292openalex-snapshot

Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.2217/14796694.4.2.241openalex-snapshot

Is There A Role For Advanced Radiation Therapy Technologies In the Treatment of Pancreatic Adenocarcinoma?

inferred← citeshttps://doi.org/10.3109/0284186x.2010.484425openalex-snapshot

Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies

inferred← citeshttps://doi.org/10.3389/fonc.2015.00145openalex-snapshot

Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.3389/fonc.2022.996537openalex-snapshot

A phantom-based analysis for tracking intra-fraction pancreatic tumor motion by ultrasound imaging during radiation therapy

inferred← citeshttps://doi.org/10.3390/cancers15133382openalex-snapshot

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?

inferred← citeshttps://doi.org/10.3390/cancers17182959openalex-snapshot

Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-Analysis

inferred← citeshttps://doi.org/10.3390/cancers2031565openalex-snapshot

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma

inferred← citeshttps://doi.org/10.3390/curroncol31100446openalex-snapshot

Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT)

inferred← citeshttps://doi.org/10.3390/ijms24010577openalex-snapshot

Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR)

inferred← citeshttps://doi.org/10.3748/wjg.v21.i26.8156openalex-snapshot

Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer

inferred← citeshttps://doi.org/10.3748/wjg.v21.i8.2281openalex-snapshot

New challenges in perioperative management of pancreatic cancer

inferred← citeshttps://doi.org/10.3857/jkstro.2009.27.3.145openalex-snapshot

The Results of Radiotherapy in Locally Advanced, Unresectable Pancreatic Cancer

inferred← citeshttps://doi.org/10.3857/roj.2014.32.2.49openalex-snapshot

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer

inferred← citeshttps://doi.org/10.3892/ijo_00000207openalex-snapshot

Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models

inferred← citeshttps://doi.org/10.3892/mco.2015.664openalex-snapshot

Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer

inferred← citeshttps://doi.org/10.3978/j.issn.2078-6891.2012.029openalex-snapshot

Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.

inferred← citeshttps://doi.org/10.6004/jnccn.2010.0073openalex-snapshot

Pancreatic Adenocarcinoma

inferred← citeshttps://doi.org/10.6004/jnccn.2017.0131openalex-snapshot

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

inferred← citeshttps://doi.org/10.6004/jnccn.2018.0012openalex-snapshot

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

inferred← citeshttps://doi.org/10.6009/jjrt.2016_jsrt_72.11.1074openalex-snapshot

The Usefulness of Using Fiducial Marker in Proton Therapy for Locally Advanced Pancreatic Cancer

inferred← citeshttps://doi.org/10.6084/m9.figshare.12544574openalex-snapshot

Additional file 6 of Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head

inferred← citeshttps://doi.org/10.6084/m9.figshare.26309002openalex-snapshot

Additional file 1 of A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study

inferred← citeshttps://doi.org/10.6084/m9.figshare.26309118openalex-snapshot

Additional file 2 of A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study

inferred← citeshttps://doi.org/10.6084/m9.figshare.26619316openalex-snapshot

Additional file 1 of Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

inferred← citeshttps://doi.org/10.6084/m9.figshare.26619319openalex-snapshot

Additional file 2 of Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

showing the first 200 of 205

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.